TerminatedPhase 2NCT00918931
Obatoclax for Systemic Mastocytosis
Studying Mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- M.D. Anderson Cancer Center
- Principal Investigator
- Srdan Verstovsek, MDUT MD Anderson Cancer Center
- Intervention
- Obatoclax Mesylate(drug)
- Enrollment
- 3 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2009 – 2010
Study locations (1)
- UT MD Anderson Cancer Center, Houston, Texas, United States
Collaborators
Gemin X
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00918931 on ClinicalTrials.gov